U.S. FDA advisers back approval for Guardant's blood-based c

By Puyaan Singh and Leroy Leo (Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of Guardant Health's blood test to detect a cancer that begins in the colon or rectum. The panel voted seven-to-two in ...

Related Keywords

United States , Bengaluru , Karnataka , India , Puyaan Singh , Leroy Leo , Arun Koyyur , Reuters , Drug Administration On , University Of Alabama , Guardant Health , Charity Morgan , Drug Administration , Epigenomic Epi , Exact Science Cologuard , Victoria Raymond ,